Advertisement
Advertisement
U.S. Markets open in 57 mins
Advertisement
Advertisement
Advertisement
Advertisement

The Trendlines Group Ltd. (TRNLY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.85000.0000 (0.00%)
At close: 12:44PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.8500
Open3.8500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range3.8500 - 3.8500
52 Week Range3.1500 - 4.2400
Volume3,334
Avg. Volume849
Market Cap62.319M
Beta (5Y Monthly)0.94
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 20, 2019
1y Target EstN/A
  • PR Newswire

    Trendlines Announces Acquisition of Portfolio Company OrthoSpin Ltd.

    The Trendlines Group Ltd. ("Trendlines") is pleased to announce the 100% acquisition ("Acquisition") of its 26.9%-owned (fully diluted) portfolio company, OrthoSpin Ltd. ("OrthoSpin"), by Synthes GMBH (part of DePuy Synthes, the Orthopaedics company of Johnson & Johnson) for a total of US$79.5 million in cash, payable in full upon closing. The total net proceeds for Trendlines from the Acquisition will be US$15.8 million after expenses, representing a 165% internal rate of return (IRR) on Trendl

  • PR Newswire

    Vensica Therapeutics Closes $16 Million Investment Round

    Vensica Therapeutics ("Vensica"), a clinical stage biopharmaceutical company, announced that it has closed an investment round of $16 million. The investment round was led by Israel Biotech Fund ("IBF"), a venture fund investing in Israeli and Israeli-related biotechnology and pharmaceutical companies. Other investors in the round include Laborie, a global urology device company, Lew Pell, an experienced medical device investor, Agriline, a trust of which Vincent Tchenguiz is a discretionary ben

  • PR Newswire

    Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million

    Fidmi Medical Ltd. (www.fidmimedical.com) has announced completion of a $2.2 million financing round and launched its FDA-cleared low-profile Percutaneous Endoscopic Gastrostomy (PEG) device in the U.S. Investors in the round include leading medical technology company Micro-Tech (Nanjing) Co., Ltd. (688029: Shanghai), The Trendlines Group (www.trendlines.com), (SGX: 42T) (OTCQX: TRNLY), and Agriline. Micro-Tech has been named Fidmi's exclusive distributor in the U.S. (www.mtendoscopy.com) and Ch

Advertisement
Advertisement